Sirolimus Combined Dexamethasone As the First-Line Therapy for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Open-Label, Prospective, Randomized Controlled Clinical Trial
Yimei Feng(Xinqiao Hospital), Xi Zhang(Army Medical University), Jia Liu(Dalian Medical University), Wenzheng Yu(Binzhou Medical University), Yang Yi(Hubei Academy of Agricultural Sciences), Zhanshu Liu(Chongqing Medical University), Ming Hou(Shandong University), Xiaoli Chen(Army Medical University), Guojun Li, Hanqing Zeng(Dalian Medical University), Han Yao(Army Medical University), Changyong Yuan(Xuzhou Medical College), Yi Liao(Chongqing Emergency Medical Center), Guoxiang Zhang(Changzhi Medical College), Chunfang Peng(Chongqing University), Hua-E Shu, Yaqing Feng(The Third People's Hospital of Dalian City)
Cited by 1
Related Papers
Recent advances in CAR-T cell engineering
|Journal of Hematology & Oncology|2020|403
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
|Journal of Hematology & Oncology|2017|256
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|Cancer Cell|2020|234
TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair
|Frontiers in Oncology|2019|115
Strategies to enhance CAR-T persistence
|Biomarker Research|2022|90